Proven Bellavista 1000E Ventilator Comes to the U.S.

vyaire bellavista 1000

Innovative ventilation system that can be used across health care settings for full range of patients. Available now in United States.

Vyaire Medical, Inc.’s bellavista 1000e ventilator has been granted 510(k) clearance from the U.S. Food and Drug Administration (FDA). It is the newest addition to Vyaire’s high-end ventilation portfolio offering a comprehensive solution for hospitals with the integration of high flow oxygen therapy and advanced synchrony support for neonatal to adult patients in a single device. Clinicians can rapidly change therapies on a broad range of patients in an effortless way. 

“We began using bellavista exclusively in 2017, when it was available in Europe. It allows us to ventilate invasive, non-invasive, nasal CPAP and perform high flow oxygen therapy with one device enabling targeted, efficient patient care in any situation” said Vincenzo Cannizzaro, MD, PhD, Deputy Chief Physician of PICU/NICU, University Children’s Hospital, Zurich, Switzerland.

Designed exclusively around enhancing the caregiver’s experience, the bellavista 1000e’s intuitive touch screen provides advanced graphics to easily visualize the patient’s pulmonary status, enhancing situational awareness for the caregiver. Whether its escalating care or weaning a patient efficiently, the bellavista 1000e ventilator simplifies the process by delivering optimal workflows with the goal of reducing operator error and ventilator lengths of stays. 

“Clinicians, respiratory therapists and bedside caregivers provided critical input in the design of this ventilator and helped us ensure we addressed their challenges in all patient care circumstances,” said Lisa Rose, Chief Marketing and Innovation Officer, Vyaire Medical. “The bellavista 1000e is a solution that provides the ultimate versatility in therapy and it can be adjusted quickly depending on patient need in time-sensitive situations. These differentiators are critical in a healthcare environment which expects innovative products to improve patient outcomes. Vyaire is dedicated to developing the kinds of systems and products that meet the needs of healthcare providers.”

Today, there are more than 8,200 bellavista 1000e ventilators in use across 92 countries outside of the United States.  The bellavista 1000e ventilator will be introduced to the U.S. healthcare market at the American Association of Respiratory Care Congress (AARC), November 9—12 2019 in New Orleans at Vyaire Booth #1219.

Source: Vyaire Medical

1 Comment

  1. So far the Bellavista ventilator is a bust in it’s USA introduction. Far to busy too many confusing screens. Too long to setup and too frequent circuit tests needed. To many unnecessary screens to find what your looking for. The target ventilation theory not easily understood or employed by most therapist’s trained in the conventional PRVC profile. Circuit has too many tubes most whistle at high peep and flow annoying family members at bedside. Too little attention and testing made for alarm setting that sound when vent automatically determines a mode switch is needed. Too much time getting vent setup to apply to a patient in emergency situation. The list of problems is endless.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.